Volatility in Hemispherx (HEB) Remains: Stock Correcting Following Friday's 27% Sell-Off
Tweet Send to a Friend
Shares of Hemispherx BioPharma (AMEX: HEB) are continuing an extremely momentous run this week, adding another 12% onto a rally ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
